1 min read

ID: 1040732

Short Link: https://gregory-ms.com/articles/1040732/

Discovery Date: 27 October 2022, 17:05:12 UTC

Published Date: 2022-10-27 10:00:00

Source: PubMed

Link: https://pubmed.ncbi.nlm.nih.gov/36301434/?fc=20210216052009&ff=20221027130511&v=2.17.8

Manual Selection: true

Machine Learning Gaussian Naive Bayes Model: false

Abstract

PURPOSE OF REVIEW: Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) with a chronic and often progressive disease course. The current disease-modifying treatments (DMTs) limit disease progression primarily by dampening immune cell activity in the peripheral blood or hindering their migration from the periphery into the CNS. New therapies are needed to target CNS immunopathology, which is a key driver of disability progression in MS. This article reviews…

Noun Phrases in Title

  • Bruton's Tyrosine Kinase Inhibition
  • Multiple Sclerosis
This is an independent project that runs on the good will of volunteers

You can help by spreading the word or by donating what you can to pay for the server costs.